Bianchetti L, Ferrier C, Beretta-Piccoli C, Fraser R, Morton J J, Ziegler W H
Clin Endocrinol (Oxf). 1986 Jul;25(1):87-95. doi: 10.1111/j.1365-2265.1986.tb03598.x.
In normal man the sympathetic nervous system could exert an inhibitory influence on aldosterone responsiveness to angiotensin II. The possible role of alpha-1 adrenoceptors in the modulation of aldosterone response was assessed by studying the changes of plasma aldosterone during infusion of angiotensin II at the doses of 1, 2, 5 and 10 ng/kg.min or after corticotrophin injection, 0.25 mg, in 9 normal subjects before and after treatment with the selective alpha-1 adrenoceptor antagonist, prazosin. Prazosin, given during 3 weeks, did not modify supine arterial pressure, heart rate and the plasma levels of angiotensin II, renin, aldosterone or adrenaline but caused a significant (P less than 0.05) increase of plasma noradrenaline. The correlation relating plasma aldosterone to plasma angiotensin II levels before and during angiotensin II infusion and the response of plasma aldosterone to corticotrophin was not modified by prazosin. These findings suggest that in normal man there is no inhibitory influence of the noradrenergic system on aldosterone responsiveness to angiotensin II mediated by an alpha-1 dependent mechanism.
在正常人体内,交感神经系统可对醛固酮对血管紧张素II的反应产生抑制作用。通过研究9名正常受试者在静脉输注剂量为1、2、5和10 ng/kg·min的血管紧张素II期间或注射0.25 mg促肾上腺皮质激素后血浆醛固酮的变化,评估了α-1肾上腺素能受体在调节醛固酮反应中的可能作用,这些受试者在使用选择性α-1肾上腺素能受体拮抗剂哌唑嗪治疗前后进行了上述研究。连续3周给予哌唑嗪,并未改变仰卧位动脉血压、心率以及血管紧张素II、肾素、醛固酮或肾上腺素的血浆水平,但导致血浆去甲肾上腺素显著升高(P<0.05)。哌唑嗪并未改变血管紧张素II输注前及输注期间血浆醛固酮与血浆血管紧张素II水平之间的相关性,以及血浆醛固酮对促肾上腺皮质激素的反应。这些发现表明,在正常人体内,去甲肾上腺素能系统不存在通过α-1依赖性机制对醛固酮对血管紧张素II的反应产生抑制作用。